Finfeed Archived Feb 03, 2016
Cancer Therapeutics CRC (CTx) has licensed a promising new cancer drug to US pharmaceutical company Merck.
Next Investors Archived Oct 28, 2015
The long term game that emerging medical cannabis company MMJ PhytoTech (ASX:MMJ) is playing is gradually paying off.
Get expert stock analysis direct in your inbox
Join OurMailing List
